StageBio, a leading international provider of GLP-compliant research, preclinical and clinical histopathology and biospecimen archiving services for life sciences industry, announces that Ms. Lecia Johnson has been appointed to Vice President, Commercial of StageBio.
The StageBio team is looking forward to exhibiting and attending The 19th European Congress of Toxicologic Pathology (ESTP). Attendees will have access to new research, educational and professional development programming, and networking opportunities for anyone working in the area of the female reproductive system and in toxicologic pathology.
The StageBio team is looking forward to attending the 2022 ESMO Congress Exhibition conference in Paris, France September 9-13, 2022.
Upgraded technology now enables StageBio to service clients in Europe.
It is with great honor that we congratulate Melanie Willis, CVT, BS, RQAP-GLP, Senior Quality Assurance Auditor, she has been elected as the inaugural SQA Director for Diversity, Inclusion, and Belonging.
StageBio is honored to introduce Lori A. Wright, RQAP-GLP, Senior Director, Quality and Regulatory.
StageBio is honored to introduce Dr. Juliana Lee, BVSc, MS, DACVP as Interim Director, Medical Device Pathology.
The StageBio team is looking forward to attending ESMO Congress 2022 in Paris, France, September 9-13, and we hope to see you there!
The StageBio team is looking forward to attending the STP 41st Annual Symposium Toxicologic Pathology of the Hematopoietic System in Austin, TX June 19-23 and we hope to see you there!
It is with great honor that we announce the promotion of Dr. Stephanie Shrader as Director of General Toxicologic Pathology at StageBio.
513.204.4400
